The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus
Abstract
PURPOSE: To investigate the efficacy and feasibility of concurrent chemoradiotherapy for locally advanced carcinoma of the esophagus. PATIENTS AND METHODS: Fifty-four patients with clinically T4 and/or M1 lymph node (LYM) squamous cell carcinoma of the esophagus were enrolled. Patients received protracted infusion of fluorouracil 400 mg/m 2/24 hours on days 1 to 5 and 8 to 12, 2-hour infusion of cisplatin 40 mg/m 2 on days 1 and 8, and concurrent radiation therapy at a dose of 30 Gy in 15 fractions over 3 weeks. Filgrastim was prophylactically administered to 35 patients. This schedule was repeated twice every 5 weeks, for a total radiation dose of 60 Gy, followed by two courses of fluorouracil (800 mg/m 2/24 hours for 5 days) and cisplatin (80 mg/m 2 on day 1). RESULTS: There were 21 patients with T4M0 disease, one with T2M1 LYM, 17 with T3M1 LYM, and 15 withT4M1 LYM. Forty-nine patients (91%) completed at least the chemoradiotherapy segment. The 18 patients (33%) who achieved a complete response included nine (25%) of the 36 with T4 disease and nine (50%) of the 18 with non-T4 disease. Major toxicities were leukocytopenia and esophagitis; there were four (7%) treatment-related deaths. Prophylactic filgrastim reduced the incidence of grade 3 or worse leukopenia without improving dose-intensity or response. With a median follow-up duration of 43 months, median survival time was 9 months. The 3-year survival rate was 23%. CONCLUSION: Despite its significant toxicity, this combined modality seemed to have curative potential even in cases of locally advanced carcinoma of the esophagus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus
Akiyama, H., Tsurumaru, M., Udagawa, H., & Kajiyama, Y. (1994) · Annals of Surgery · doi:10.1097/00000658-199409000-00012 · Cited by 901
al-Sarraf, M., Martz, K., Herskovic, A., Leichman, L., Brindle, J. S., Vaitkevicius, V. K., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.277 · Cited by 739
Fujita, H., Kakegawa, T., Yamana, H., Shima, I., Toh, Y., Tomita, Y., Fujii, T., Yamasaki, K., Higaki, K., Noake, T., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199511000-00008 · Cited by 396
Comparison of CT and MR imaging in staging of neck metastases.
Curtin, H. D., Ishwaran, H., Mancuso, A. A., Dalley, R. W., Caudry, D. J., & McNeil, B. J. (1998) · Radiology · doi:10.1148/radiology.207.1.9530307 · Cited by 394
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
Scanlon, K. J., Newman, E. M., Lu, Y., & Priest, D. G. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8923 · Cited by 367
Forastiere, A. A., Orringer, M. B., Perez-Tamayo, C., Urba, S. G., & Zahurak, M. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1118 · Cited by 366
Coia, L. R., Engstrom, P. F., Paul, A. R., Stafford, P. M., & Hanks, G. E. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90134-p · Cited by 266
Toxicity Grading Criteria of the Japan Clinical Oncology Group
Tobinai, K., Kohno, A., Shimada, Y., Watanabe, T., Tamura, T., Takeyama, K., Narabayashi, M., Fukutomi, T., Kondo, H., Shimoyama, M., et al. (1993) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039642 · Cited by 168
Cited by
Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
Ohashi, S., Miyamoto, S., Kikuchi, O., Goto, T., Amanuma, Y., & Muto, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.054 · Cited by 530
Self-citationRecent progress in multidisciplinary treatment for patients with esophageal cancer
Watanabe, M., Otake, R., Kozuki, R., Toihata, T., Takahashi, K., Okamura, A., & Imamura, Y. (2020) · Surgery Today · doi:10.1007/s00595-019-01878-7 · Cited by 428
Kato, K., Muro, K., Minashi, K., Ohtsu, A., Ishikura, S., Boku, N., Takiuchi, H., Komatsu, Y., Miyata, Y., & Fukuda, H. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.06.033 · Cited by 353
Self-citationKato, H., Sato, A., Fukuda, H., Kagami, Y., Udagawa, H., Togo, A., Ando, N., Tanaka, O., Shinoda, M., Yamana, H., et al. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp069 · Cited by 295
Self-citation
Metadata
- Authors
- Ohtsu, A., Boku, N., Muro, K., Chin, K., Muto, M., Yoshida, S., Satake, M., Ishikura, S., Ogino, T., Miyata, Y., Seki, S., Kaneko, K., & Nakamura, A.
- Venue
- Journal of Clinical Oncology
- Published
- 1999-09
- Volume
- 17
- Issue
- 9
- Pages
- 2915-2915
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2120518038
- Cited by
- 437
- References
- 10
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus. https://app.cochat.ai/papers/10.1200/jco.1999.17.9.2915
- The paper
- Ohtsu, A., Boku, N., Muro, K., Chin, K., Muto, M., Yoshida, S., Satake, M., Ishikura, S., Ogino, T., Miyata, Y., Seki, S., Kaneko, K., & Nakamura, A. (1999). Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1999.17.9.2915
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.